Hospital Pharmacy Europe - Dermatology,

Click here

Saturday 25 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Dermatology

Magazine	Sponsored content
News	Video

Wed 10 Apr

Psoriasis linked with high blood pressure
Psoriasis is a serious, inflammatory, noncommunicable disease, affecting more than 125 million people all over the world. People...

Tue 2 Apr

Ameluz: drug evaluation
Ameluz® is a new gel formulation containing 10% 5-aminolevulinic acid (ALA) in a nanoscale lipid vesicle formulation that...

Tue 12 Mar

Alitretinoin in severe chronic hand eczema
This article provides an overview of the background to the therapeutic use of alitretinoin in chronic hand eczema, including its...

Thu 7 Mar

Global psoriasis
More than 125 million people all over the world have psoriasis - a condition that is continuously under-diagnosed and...

Mon 25 Feb

Chronic hives
Late-breaking results from ASTERIA II, a Phase III placebo-controlled study, demonstrated that omalizumab provided effective...

Mon 29 Oct
2012

Psoriasis Mandate
Promising interim results from the Psoriasis Mandate have been released to mark World Psoriasis Day. To date 1145 people across...

Mon 1 Oct
2012

STELARA® and moderate to severe plaque psoriasis
A series of data presentations released today at the 21st European Academy of Dermatology and Venereology (EADV) congress, in...

Thu 27 Sep
2012

Novartis data in patients with plaque psoriasis
Novartis announced today new Phase II data showing AIN457 (secukinumab) may significantly improve moderate-to-severe plaque...

Thu 6 Sep
2012

Evaluation of melanoma care in UK
A group of eminent melanoma specialists has today published an evaluation of melanoma care in the UK, setting out a vision for...

Tue 7 Jun
2011

Treatment prolongs metastatic melanoma patients' lives
Phase III study of Yervoy™ (ipilimumab) meets primary endpoint of overall survival

Wed 25 May
2011

Stelara® (ustekinumab) data shows consistent safety for psoriasis patients
Results from a large psoriasis-focused clinical trial programme presented at the World Congress of Dermatology

Web design, hosting and programming by ModeZero